Sarcoma, Spindle Cell
Showing 1 - 25 of >10,000
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)
Recruiting
- Clear Cell Sarcoma of Soft Tissue
-
Wuhan, Hubei, ChinaChina, Hubei Province
Jul 19, 2023
Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)
Terminated
- Clear Cell Sarcoma
- AMG 337
-
El Segundo, California
- +1 more
Dec 9, 2022
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)
Not yet recruiting
- Ewing Sarcoma
- +3 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 27, 2023
Advanced Sarcoma Trial (NKG2D-CAR memory T cell)
Not yet recruiting
- Advanced Sarcoma
- NKG2D-CAR memory T cell
- (no location specified)
Oct 17, 2023
Autologous Natural Killer Cell Activity in Primary Cancer Cell
Recruiting
- Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
May 19, 2023
Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston
Active, not recruiting
- Langerhans Cell Histiocytosis (LCH)
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 26, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)
Recruiting
- Sarcoma, Clear Cell
- CPI-613 + Hydroxychloroquine
-
Duarte, California
- +7 more
Nov 10, 2022
Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)
Recruiting
- Soft Tissue Sarcoma
- +9 more
- Patient with Soft Tissue Sarcoma
-
Besancon, France
- +13 more
Oct 11, 2022
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))
Recruiting
- Melanoma
- +11 more
- Non-invasive adhesive system (patch)
-
Nizhny Novgorod, Russian Federation
- +1 more
Jun 12, 2022
Genetic Basis of Melanocytic Nevi
Recruiting
- Melanocytic Nevi
- Collecting Nevi
-
Sacramento, CaliforniaUniversity of California-Davis, Department of Dermatology
Nov 23, 2022
Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)
Not yet recruiting
- Synovial Sarcoma
- Fludarabine phosphate
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023